Pluri Subsidiary Coffeesai Partners with Mexico's INCAFECH to Advance Cell-Based Coffee Manufacturing

Pluri Inc. (NASDAQ:PLUR) is one of the best long term penny stocks with huge upside potential. On October 8, Pluri announced that its wholly-owned subsidiary, Coffeesai Ltd., had signed a collaboration agreement with the Instituto del Café de Chiapas/INCAFECH, a public body of the State of Chiapas, Mexico. The purpose of this state-backed collaboration is to advance cell-based coffee manufacturing in Mexico, positioning Chiapas, the country’s leading coffee-growing region, as a hub for innovation.

Coffeesai develops sustainable cell-based coffee products, using Pluri’s proprietary 3D cell expansion platform and two decades of expertise to create solutions. The partnership outlines a multi-phase, capital-light roadmap to de-risk commercialization.

This effort is designed to create shareholder value for Plurithrough potential non-dilutive revenues from License and Technology Transfer, as well as recurring revenue streams via Royalty-bearing models, joint ventures, and potential sales tied to large-scale production.

Pluri Inc. (NASDAQ:PLUR) is a biotechnology company that researches, develops, and manufactures cell-based products, cell therapeutics, and related technologies for various industries.

While we acknowledge the potential of PLUR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.